Products - Systemic lupus erythematosus | Topic | NICE

Showing 2 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Obinutuzumab with immunosuppressive therapies for treating lupus nephritis [ID6420]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
11 March 2026
Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 [TSID11828]
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC